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ABSTRACT Acetylcholine modulates the virulence of Candida albicans and regu-
lates an appropriate immune response to infection in a Galleria mellonella infection
model. Indeed, the evidence suggests that C. albicans possesses a functional cholin-
ergic receptor that can regulate ﬁlamentous growth and bioﬁlm formation. Further-
more, G. mellonella immune cell subsets possess repertories of cholinergic receptors
which regulate an effective and appropriate cellular immune response to C. albicans
infection. This study aimed to investigate the cholinergic receptor subtype involved
in regulation of ﬁlamentous growth and bioﬁlm formation by C. albicans and deter-
mine the roles of cholinergic receptors in modulation of G. mellonella immune cell
subsets. The general muscarinic receptor agonist, pilocarpine hydrochloride, inhib-
ited C. albicans bioﬁlm formation and pathogenicity, a phenomenon that could be
reversed using the general muscarinic receptor antagonist, scopolamine. Pilocarpine
hydrochloride protected G. mellonella larvae from C. albicans infection via inhibition
of C. albicans ﬁlamentation and appropriate regulation of cellular immunity. How-
ever, scopolamine abrogated the capacity of pilocarpine hydrochloride to protect G.
mellonella larvae from C. albicans infection. Furthermore, acetylcholine and pilo-
carpine hydrochloride exhibited differential modulatory capabilities on Galleria mello-
nella hemocyte responses to C. albicans. The data in this article demonstrate that a
muscarinic receptor modulates C. albicans ﬁlamentation and bioﬁlm formation. Fur-
thermore, the results suggest that G. mellonella hemocyte subsets possess unique
repertoires of cholinergic receptors that regulate their differentiation, activation, and
function in contrasting manners. Therefore, targeting cholinergic receptors by repur-
posing currently licensed cholinergic drugs may offer novel therapeutic solutions for
the prevention or treatment of fungal infections.
IMPORTANCE Candida albicans is the most common human fungal pathogen with
an estimated crude mortality rate of 40%. The ability of the organism to switch from
the yeast to hyphal form and produce bioﬁlms are important virulence factors. C. al-
bicans infections are combatted by the host immune system. However, Candida trig-
gers a strong inﬂammatory response that, if not appropriately regulated, can dam-
age host tissues. Therefore, it is important that the host immune response eliminates
the fungus but limits tissue damage. This study provides evidence that targeting
cholinergic receptors cannot only curb the virulence of C. albicans by inhibiting ﬁla-
mentous growth and bioﬁlm formation but can also appropriately regulate the host
immune response to induce rapid clearance with limited damage to vital tissues.
This article provides evidence that repurposing licensed drugs that target cholinergic
receptors may offer novel therapeutic solutions for the prevention or treatment of
fungal infections.
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Acetylcholine (ACh) is synthesized by almost every cell of the human body, and itsfunctions go way beyond those of a classical neurotransmitter (1–3). ACh is known
to modulate pathogen-driven immune responses, downregulating potentially damag-
ing chronic inﬂammation and promoting favorable disease outcomes in selected in vivo
models of bacterial sepsis (4–7). Furthermore, human immune cells express both
nicotinic and muscarinic acetylcholine receptors (nAChRs and mAChRs). These recep-
tors have been demonstrated to modulate cellular immunity against bacterial patho-
gens via cholinergic-dependent mechanisms (2, 8–10).
Evidence suggests that bacteria and fungi are capable of synthesizing ACh (11–13).
However, very little is known about the cholinergic receptor repertoire of these
microorganisms. Several bacterial species possess homologs of mammalian nicotinic
receptors (14, 15), although the functional roles of these receptors have yet to be
elucidated. To date, there are no studies that have identiﬁed or characterized fungal
cholinergic receptors. However, sequencing of the Candida albicans genome has
suggested that this organism possesses putative cholinergic receptor genes (16).
Acetylcholine has been demonstrated to promote favorable disease outcomes to C.
albicans infection in a Galleria mellonella infection model (17). Acetylcholine modulates
the pathogenicity of C. albicans by inhibiting morphogenesis, bioﬁlm formation, and
the expression of virulence factors. In addition, ACh promotes an effective cellular
immune response to fungal infection, facilitating rapid clearance from infected tissues
and affording protection from chronic-inﬂammation-induced damage of vital tissues
(17).
The innate immune system plays a crucial role in protection against systemic C.
albicans infections, as evidenced by the fact that immunocompromised, critically ill, and
elderly patients show increased susceptibility. Insects lack an acquired immune system
but possess a complex and effective innate immune system, which can be divided into
humoral and cellular defense components. The cellular defenses are deﬁned as
hemocyte-mediated responses and involve processes such as phagocytosis and encap-
sulation (18). G. mellonella possesses at least six hemocyte subtypes. However, plas-
matocytes and granulocytes are the most abundant circulating cells in G. mellonella
hemolymph (19). These cells have similar characteristics to human neutrophils (20) and
the ability to respond to ACh (17). Human immune cells, including neutrophils, possess
various repertoires of nAChRs and mAChRs, and activation of speciﬁc receptors can
have different consequences for immune function (21–23).
Advancements in our understanding of human cholinergic receptors and their roles
in various pathologies have led to the discovery of a plethora of small-molecule
agonists and antagonists with therapeutic potential. Many of these molecules have
been developed for treatment of conditions whose pathology is deﬁned by loss or gain
of cholinergic function, such as neurodegenerative disorders (24). However, a variety of
cholinergic drugs have been utilized to research the effects of cholinergic receptors on
nonneurological pathologies, including bacterial sepsis, and investigated for their
therapeutic effectiveness in inﬂammatory disease (25–27).
Repositioning of cholinergic drugs for the treatment of candidiasis may provide new
avenues for therapeutic strategies. Hence, the aims of this study were to begin to
delineate the cholinergic receptor subtype responsible for the modulation of bioﬁlm
formation by C. albicans and to investigate in further detail the role of cholinergic
receptor subtypes on cellular immunity against C. albicans infection in a G. mellonella
infection model.
RESULTS
Pilocarpine hydrochloride speciﬁcally inhibits Candida albicans bioﬁlm forma-
tion and pathogenicity through interaction with a muscarinic-like receptor. Ace-
tylcholine inhibits C. albicans bioﬁlm formation (17). Therefore, the effect of a nonspe-
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ciﬁc nicotinic receptor agonist, SIB1508Y maleate (SIBm), and a nonspeciﬁc muscarinic
receptor agonist, pilocarpine hydrochloride (PHCl), on C. albicans bioﬁlm formation was
investigated to determine whether this was due to activation of a speciﬁc subtype of
cholinergic receptor.
Biomass quantiﬁcation assays revealed that SIBm had no effect on C. albicans bioﬁlm
formation in vitro (Fig. 1A). In contrast, PHCl caused a dose-dependent decrease in
bioﬁlm biomass, with statistically signiﬁcant reductions observed with concentrations
ranging between 0.39 and 50 mM (all P 0.001) (Fig. 1B). The XTT metabolic assay
revealed that SIBm had no effect on C. albicans metabolic activity (Fig. 1C). However, a
slight but signiﬁcant reduction in C. albicans metabolic activity compared to the
untreated control (0 mM) was observed when treated with PHCl concentrations ranging
between 3.125 and 50 mM (all P 0.01) (Fig. 1D).
Reductions in metabolic activity are associated with reduced bioﬁlm formation but
can also be attributed to cell death. A planktonic MFC was performed according to the
CLSI M-27A broth microdilution methodology (28) and revealed that none of concen-
trations of SIBm or PHCl investigated possessed fungicidal activity (data not shown). In
addition, PHCl had no destabilizing effects on the C. albicans cell wall as observed by
measuring both PI uptake (Fig. 1E) and ATP release (Fig. 1F). Microscopy was also
employed to further ensure that PHCl was speciﬁcally inhibiting ﬁlamentation and not
affecting cell viability. Light microscopy (LM) (Fig. 2A to E) revealed that PHCl inhibited
ﬁlamentation and bioﬁlm formation in a dose-dependent manner. Furthermore, visu-
ally, in the presence of increasing concentrations of PHCl, more C. albicans cells
maintained a yeast morphology, suggesting that PHCl was inhibiting the yeast-to-
hypha transition. Scanning electron microscopy (SEM) analysis (Fig. 2F to J) further
conﬁrmed the fact that PHCl inhibited bioﬁlm formation due to inhibition of the
yeast-to-hypha transition in a dose-dependent manner. Fluorescence microscopy (FM)
(Fig. 2K to O) with CFW (blue) and PI staining (red) revealed no visible differences in cell
viability between any of the concentrations of PHCl investigated and therefore con-
ﬁrmed that PHCl was not toxic to C. albicans at the concentrations used in this study.
To ensure that PHCl was speciﬁcally targeting a receptor with homology to human
muscarinic receptors, bioﬁlm biomass and metabolic activity assays were repeated in
the presence of different concentrations of the nonspeciﬁc muscarinic receptor antag-
onist scopolamine (SCP). SCP inhibits the PHCl-induced reduction in bioﬁlm formation
in a dose-dependent manner with concentrations ranging from 64 to 128 m, revealing
no signiﬁcant differences in bioﬁlm biomass in the presence of 25 mM PHCl compared
to the control (Fig. 3A). Furthermore, all concentrations of SCP abolished any PHCl-
induced reductions in metabolic activity (Fig. 3B).
As hydrophobicity is a characteristic related to C. albicans bioﬁlm formation (29), the
effect of PHCl on C. albicans cell surface hydrophobicity was investigated using the
microbial adhesion to hydrocarbon (MATH) assay. A statistically signiﬁcant increase in
cell surface hydrophobicity of C. albicans cells cultured as a bioﬁlm compared to
planktonic cells was observed (P 0.05) (Fig. 3C). Interestingly, when C. albicans
bioﬁlms were cultured in the presence of 25, 12.5 (both P 0.01), and 6.25 (P 0.05)
mM PHCl, there was a statistically signiﬁcant decrease in cell surface hydrophobicity
(Fig. 3C).
Pilocarpine hydrochloride speciﬁcally modulates the pathogenesis of Candida
albicans infection in a Galleria mellonellamodel. Bioﬁlm formation is associated with
C. albicans pathogenicity, and ACh has previously been shown to protect G. mellonella
larvae from C. albicans-induced mortality (17). Therefore, the effect of PHCl on C.
albicans pathogenicity in vivo was investigated using a G. mellonella killing assay. PHCl
alone (10.5 mM) had no adverse effects on survival of the larvae (Fig. 4A). Indeed, PHCl
protects G. mellonella larvae from C. albicans-induced mortality in a dose-dependent
manner compared to larvae inoculated with C. albicans alone observed using 10.5 and
6.25 mM PHCl (P 0.001 and P 0.05, respectively; as determined using the log rank
test) (Fig. 4A). Furthermore, SCP (6.25 mM) alone had no adverse effects on the survival
of the larvae. In fact, in the presence of PHCl and SCP, the survival of the larvae was
Pilocarpine Protects against C. albicans Infection
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FIG 1 The general muscarinic receptor agonist pilocarpine hydrochloride inhibits Candida albicans bioﬁlm
formation in vitro. (A and B) Bioﬁlm biomass was assessed using the crystal violet assay after C. albicans was
cultured for 24 h in RPMI 1640 containing different concentrations of SIBm (0 to 10 mM) (A) and PHCl (0 to 50 mM)
(B). Data are expressed as raw OD595 values, and the bars represent the mean values (plus standard deviations [SD]
[error bars]) from triplicate wells of six independent experiments (n 6). (C and D) Bioﬁlm metabolic activity was
assessed using the XTT assay after C. albicans was cultured for 24 h in RPMI 1640 containing different concentra-
tions of SIBm (0 to 10 mM) (C) and PHCl (0 to 50 mM) (D). Data are expressed as percent metabolic activity
compared to untreated controls (0 mM PHCl), and the bars represent the mean values (SD) from triplicate wells
of six independent experiments (n 6). For panels A to D, values that are signiﬁcantly different compared to the
control values (0 mM SIBm or PHCl) are indicated by asterisks as follows: *, P 0.05; **, P 0.01; ***, P 0.001. (E
and F) The effect of PHCl on the permeability of the C. albicans cell wall was investigated using a propidium iodide
(PI) uptake (E) and ATP release assay (F). For the PI uptake assay, data are shown as ﬂuorescence intensity units,
and the bars represent the mean values (SD) from triplicate wells of three independent experiments (n 3).
Heat-killed (HK) and chlorhexidine (CHX) (0.2%)-treated C. albicans were included as positive controls, and cells in
RPMI 1640 alone were included as a negative control. For the ATP release assays, data are shown as nanomolar
concentrations of ATP release, and the bars represent the mean values (SD) from triplicate wells of three
independent experiments (n 3). Chlorhexidine (0.2%)- and fulvic acid (2.0%)-treated C. albicans cells were
included as positive controls, and cells in RPMI 1640 alone were included as a negative control. *, P 0.05; **,
P 0.01 compared to the control (cells in RPMI 1640 alone).
Nile et al.
January/February 2019 Volume 4 Issue 1 e00689-18 msphere.asm.org 4
 o
n
 April 24, 2019 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
comparable to those inoculated with C. albicans alone, suggesting that SCP inhibited
the PHCl-induced protection against C. albicans infection (Fig. 4B).
To visualize the effects of PHCl alone and in combination with SCP on C. albicans
pathogenicity and G. mellonella hemocyte responses to infection, in vivo histological
analysis was performed. Control sham-injected larvae after both 24 and 48 h demon-
strated the presence of small hemocyte aggregates, adjacent to the gut and the
tracheal system, resembling human MALT (mucosa-associated lymphoid tissue) and
BALT (bronchus-associated lymphoid tissue). Furthermore, some hemocytes were also
detected close to the fat body, near hemocoel cavities and distributed as a monolayer
in the subcuticular areas (Fig. 4C, panels i and vi).
Twenty-four hours postinoculation, the hemocyte response in PHCl-injected larvae
was characterized by uniformly dispersed small melanized nodules and an increase in
circulating hemocytes (Fig. 4Cii). SCP alone resulted in poor immune activation and
failed to induce melanization (data not shown). In larvae inoculated with C. albicans
alone, the hemocyte response was characterized by melanized nodules of intermediate
size, mainly located in the subcuticular area and in the fat body, with nodules found
only rarely in paratracheal areas (Fig. 4Ciii). In contrast, the hemocyte response in larvae
inoculated with C. albicans plus PHCl was characterized by the presence of single
melanized hemocytes or very small aggregates of hemocytes with melanin deposition
surrounding yeast cells. These aggregates were uniformly distributed in the hemo-
lymph, close to the fat body and in peritracheal tissues. In addition, no ﬁlamentous
growth was detected (Fig. 4Civ). In contrast, larvae inoculated with C. albicans SC5314
and treated with PHCl and SCP showed the presence of medium-sized nodules with
scanty melanization and poor hemocyte recruitment into invaded tissues. Furthermore,
poorly melanized yeast cells and hyphae were seldom detected in the nodules
(Fig. 4Cv), similar to larvae infected with C. albicans alone (Fig. 4Ciii).
Forty-eight hours postinoculation, PHCl-injected larvae showed very few and small
nodules with faint melanization (Fig. 4Cvii). Larvae infected with C. albicans alone
showed increased hemocytes in the subcuticular, intestinal, and paratracheal areas with
FIG 2 The general muscarinic receptor agonist pilocarpine hydrochloride inhibits ﬁlamentation and bioﬁlm formation in vitro without
affecting cell viability. (A to J) To assess the effects of PHCl on C. albicans morphology and viability, microscopy was employed. Light
microscopy (LM) (A to E) and scanning electron microscopy (SEM) (F to J) was performed to visualize changes in bioﬁlm biomass and C.
albicans cell morphology after culture for 24 h in RPMI 1640 containing different concentrations of PHCl (0 to 50 mM). Representative
images are shown from duplicate coverslips of three independent experiments. YC, yeast cells; PH, pseudohyphae; TH, true hyphae. Bars,
100 m (A to E) and 700 m (F to J). (K to O) Fluorescence microscopy (FM) was performed to assess cell viability. C. albicans was cultured
for 24 h in RPMI 1640 containing different concentrations of PHCl, and viability was assessed using calcoﬂuor white (blue) and propidium
iodide (red) staining. Representative images are shown from duplicate coverslips of three independent experiments. Bars, 100 m.
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large nodules and multifocal melanization and heavy damage of the fat body. Hyphal
invasion of the intestinal walls, and to a lesser extent, of the bronchial system was also
detected (Fig. 4Cviii). In contrast, larvae infected with C. albicans plus PHCl exhibited
decreased inﬂammation and less aggressive fungal inﬁltration of vital larval tissues,
with only small melanized nodules mainly distributed in subcuticular areas. In addition,
C. albicans hypha formation was not observed, and there was less microvacuolization
of the fat body (Fig. 4Cix). When treated with both PHCl and SCP, C. albicans infection
resulted in hyphal invasion of the intestinal walls (Fig. 4Cx), with a histological picture
similar to larvae infected with C. albicans alone (Fig. 4Cviii).
Pilocarpine hydrochloride and acetylcholine differentially modulate hemocyte
responses to C. albicans both in vitro and in vivo. It has previously been demon-
strated that ACh promotes G. mellonella hemocyte function (17). Therefore, the effects
of PHCl on hemocyte cellularity, subtypes, and nodule formation during the pathogen-
FIG 3 Pilocarpine hydrochloride acts through a speciﬁc muscarinic-like receptor to inhibit bioﬁlm formation and modulate cell
wall hydrophobicity. (A) Bioﬁlm biomass was assessed using the crystal violet assay after C. albicans was cultured for 24 h in
RPMI 1640 containing 25 mM PHCl and different concentrations of the nonspeciﬁc muscarinic receptor antagonist scopol-
amine (SCP) (0 to 128 M). Data are expressed as raw OD595 values, and the bars represent the mean values (SD) from
triplicate wells of three independent experiments (n 3). Candida albicans was cultured in the absence of any compound, in
the presence of PHCl alone, and in the presence of SCP alone as controls. #, signiﬁcantly different from cells cultured in the
absence of any compound; *, signiﬁcantly different from cells cultured in PHCl alone; * or #, P 0.05; ** or ##,  P 0.01; ***
or ###, P 0.001. (B) Bioﬁlm metabolic activity was assessed using the XTT assay after C. albicans was cultured for 24 h in RPMI
1640 containing 25 mM PHCl and different concentrations of the nonspeciﬁc muscarinic receptor antagonist scopolamine
(SCP) (0 to 128 M). Data are expressed as percent metabolic activity compared to untreated controls (0 mM PHCl or SCP), and
the bars represent the mean values (SD) from triplicate wells of three independent experiments (n 3). Candida albicans
cultured in the presence of PHCl and SCP alone acted as controls. *, signiﬁcantly different from cells cultured in SCP alone; ***,
P 0.001. (C) Cell wall hydrophobicity was assessed using the MATH assay (29). The bars represent the mean values (SD)
from duplicate samples of ﬁve independent experiments (n 5). #, signiﬁcantly different from cells cultured planktonically; *,
signiﬁcantly different from cells cultured as a bioﬁlm in the absence of PHCl.
Nile et al.
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esis of C. albicans infection were assessed and compared to the effects of ACh (Fig. 5
and Table 1).
An increase in hemocyte cellularity with a predominance of plasmatocytes, granu-
locytes, and spherulocytes was observed 24 h after exposure to C. albicans alone in
vitro. The hemocytes formed small, mainly two-dimensional, melanized nodules. Fur-
thermore, aggregates of yeast cells and hyphae were observed, as well as coagulation
ﬁbers similar to neutrophil extracellular traps (NETs) (Fig. 5Aii and Table 1). ACh alone
induced an increase in cellularity, with a predominance of plasmatocytes and granu-
locytes, but no spherulocytes. Cell aggregation was more evident as well as multidi-
mensional nodule formation with no visible melanization (Fig. 5Aiii and Table 1).
Similarly, PHCl induced hemocyte aggregation, leading to multidimensional nodule
formation. However, nodules were smaller and consisted mainly of plasmatocytes, a
few granulocytes, and no spherulocytes (Fig. 5Aiv and Table 1). In the presence of C.
albicans plus ACh, there was an increase in cellularity with a predominance of plas-
matocytes, granulocytes, and spherulocytes. A strong induction of aggregation and
multidimensional nodule formation with no melanization was also clearly visible
(Fig. 5Av and Table 1). In contrast, although an increase in cellularity was also evident
in C. albicans-plus-PHCl treated hemocytes, granulocyte and spherulocyte numbers
were reduced compared with cells treated with C. albicans plus ACh. There was also
FIG 4 Pilocarpine hydrochloride acts through muscarinic-like receptors to prolong survival of Candida albicans-infected Galleria mellonella by
inhibiting bioﬁlm formation and modulating host immunity in vivo. The effect of PHCl on the outcome of systemic candidiasis was investigated
using a G. mellonella infection model. (A) A Kaplan-Meier plot shows the effects of different concentrations of PHCl on the survival of Candida
albicans-infected larvae. The data are derived from three independent experiments with groups of 16 larvae (n 48). ***, P 0.001; *, P  0.05,
as determined by the log rank test in comparison to larvae inoculated with C. albicans alone. PBS alone and PHCl alone-injected larvae were used
as controls and had no effect on larvae survival. (B) To verify speciﬁcity, C. albicans-infected larvae were also inoculated with PHCl and SCP in
combination. The data are derived from three independent experiments with groups of 16 larvae (n 48). *, P 0.05, as determined by the log
rank test in comparison to larvae inoculated with C. albicans. Larvae injected with PBS alone and SCP alone were used as controls, and PBS and
SCP alone had no effect on larva survival. (C) Histological analysis of larvae was performed at 24 and 48 h postinoculation using hematoxylin and
eosin (HE) and periodic acid-Schiff (PAS) staining. (i and vi; HE) (ii and vii; HE) larva inoculated with PHCl (6.25 mM) alone. (iii and viii; PAS) larvae
infected with C. albicans. (iv and ix; HE) larvae infected with C. albicans in the presence of PHCl (6.25 mM). (v and x; PAS). Larvae infected with
C. albicans in the presence of PHCl (6.25 mM) and SCP (6.25 mM). Asterisks highlight melanized nodules, whereas arrows show C. albicans cells
and hyphae. Representative images are shown from histological analysis of two larvae for each condition from three independent experiments.
Fb, fat body; Ct, cuticle; GI, gastrointestinal tract; T, trachea; Nd, nodule. Bars, 250 m (panels i, v, and ix) and 100 m (panels ii, iii, iv, vi, vii, viii,
and x).
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limited cell aggregation and the formation of small two-dimensional nodules with no
melanization (Fig. 5Avi and Table 1).
To determine whether the effects observed in vitro could be differently affected in
vivo due to tissue secretion of regulatory molecules, the same analysis was performed
on hemocytes isolated from G. mellonella larvae 24 h after infection with C. albicans in
the presence and absence of ACh or PHCl. Sham-infected larvae were used as a control
(Fig. 5Bi and Table 1). Comparison with the control cells in vitro (Fig. 5Ai and Table 1)
FIG 5 Effects of pilocarpine hydrochloride and acetylcholine on hemocyte responses to C. albicans in vitro and in vivo. (A) In the in vitro study, hemocytes
isolated from untreated larvae were either left unstimulated (control) (i) or stimulated with C. albicans (ii), ACh (iii), PHCl (iv), C. albicans plus ACh (v), and C.
albicans plus PHCl for 24 h. (B) In the in vivo study, larvae were bled 24 h after sham inoculation with PBS (control) (i) or inoculation with C. albicans (ii), ACh
(iii), PHCl (iv), C. albicans plus ACh (v), and C. albicans plus PHCl. Representative images are shown from hematoxylin and eosin staining of hemocytes from three
larvae for each condition from three independent experiments. Bars, 100 m.
TABLE 1 Effects of pilocarpine hydrochloride and acetylcholine on hemocyte cellularity and subtype characteristics in vitro and in vivo
Condition
and treatmenta Cellularity Hemocyte subsetb Nodule
C. albicanscPr Gr Pl Co Sp Ad Oe Size Melanization
In vitro
CTR Low          
SC5314 High        Medium  
ACh High        Medium  
PHCl Low          
SC5314/ACh High        Large  
SC5314/PHCl High        Small  
In vivo
CTR Low          
SC5314 High        Large  
ACh Intermediate        Medium  
PHCl Low          
SC5314/ACh Intermediate        Large  
SC5314/PHCl Intermediate        Small  
aGalleria mellonella larvae were inoculated with PBS (control [CTR]), C. albicans SC5314, acetylcholine (ACh), pilocarpine hydrochloride (PHCl), C. albicans plus ACh
(SC3514/ACh), and C. albicans plus PHCl (SC5314/PHCl).
bPr, prohemocytes; Gr, granulocytes; Pl, plasmatocytes; Co, coagulocytes; Sp, spherulocytes; Ad, adipocytes; Oe, oenocytes. Immune cell subtype quantiﬁcation was
scored as follows: , absent/rare; , 1 to 10%; , 11 to 30%; , 31 to 50%.
cC. albicans presence was quantiﬁed as follows: , absent; , few cells; , multiple yeast agglomerate usually embedded in nodules; , abundant yeasts and/or
hyphae with widespread diffusion in nodules.
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revealed a greater number of cells with ﬁnely vacuolated cytoplasm, resembling
spherulocytes and adipocytes. For all experimental conditions, the in vivo observations
substantially overlapped the in vitro observations. However, overall cellularity was
slightly reduced in vivo compared to in vitro due to tissue sequestration of hemocytes.
With respect to speciﬁc treatments, hemocytes from C. albicans-infected larvae re-
vealed a predominance of granulocytes and spherulocytes (Fig. 5Bii and Table 1)
compared to hemocytes stimulated with C. albicans alone in vitro. In addition, the
granulocytes were larger and contained large vacuoles within melanized cytoplasm
compared with the small two-dimensional melanized nodules observed in the cells in
vitro (Fig. 5Aii and Table 1). Hemocytes from larvae inoculated with ACh or PHCl alone
and with C. albicans plus PHCl (Fig. 5Biii, iv, and vi, respectively; Table 1) showed similar
cellularity and differentiation properties to hemocytes exposed to the same compound
in vitro (Fig. 5Aiii, iv, and vi, respectively; Table 1). In contrast, hemocytes isolated from
larvae infected with C. albicans plus ACh (Fig. 5Bv and Table 1) showed increased
melanization compared to hemocytes cultured in vitro and infected with C. albicans
alone (Fig. 5Av and Table 1).
DISCUSSION
Acetylcholine has previously been found to inhibit C. albicans virulence, both in vitro
and in vivo, leading to the hypothesis that C. albicans possesses putative cholinergic
receptors (17, 30). ACh is a general cholinergic receptor agonist with activity against
both nicotinic ACh receptors (nAChR) and muscarinic ACh receptors (mAChR). In this
study, the general nicotinic agonist SIB1508Y maleate had no effect on C. albicans
bioﬁlm formation in vitro. In contrast, PHCl, a nonspeciﬁc muscarinic agonist, inhibited
ﬁlamentation and bioﬁlm formation. PHCl had no fungicidal activity, and the pharma-
cological speciﬁcity of the response was conﬁrmed both in vitro and in vivo using a
general muscarinic receptor antagonist, scopolamine. Therefore, C. albicans possesses
an uncharacterized cholinergic receptor involved in regulating ﬁlamentation similar in
phenotype to human muscarinic receptors.
PHCl is used clinically to treat xerostomia and glaucoma (31, 32). Pharmacological
studies using in vitro and in vivo models indicate that, despite being a general
muscarinic agonist, PHCl has a predominance for M3 and M1 (M3M1) muscarinic
receptors in mammals (33). Muscarinic receptors are G protein-coupled receptors
specialized in responding to ligands involved in cell-cell communication (34). Fungi
express a number of G protein-coupled receptors that play vital roles in sensing
extracellular signals (34). In C. albicans, G protein-coupled receptors have been shown
to regulate ﬁlamentation. However, current evidence suggests that G protein-coupled
receptors promote ﬁlamentation and bioﬁlm formation (34, 35). In addition, the general
muscarinic receptor antagonist dicyclomine attenuates C. albicans hypha formation by
upregulating tup1 expression, the master negative regulator of hypha formation (36).
However, in this study, dicycloamine was found to be toxic to C. albicans, and the
authors did not discriminate between direct fungicidal activity and speciﬁc on target
effects of the compound (36).
The data herein suggest that C. albicans possesses a G protein-coupled receptor that
can negatively regulate ﬁlamentation and bioﬁlm formation. To date, our knowledge of
fungal G protein receptors and their roles in regulation of cellular phenotype is not
complete, and a number of orphan receptors have still to be functionally characterized
(34). However, human studies have shown that different muscarinic receptor subtypes
can have opposing functions (37, 38). It is therefore feasible that C. albicans possesses
more than one G protein-coupled receptor that can differentially modulate ﬁlamenta-
tion, bioﬁlm formation, and virulence. Further research is required to conﬁrm this
hypothesis.
Both M1 and M3 receptors utilize intracellular calcium as a second messenger (39).
There is evidence that suggests that unrestricted calcium uptake can inhibit C. albicans
mycelial growth, which indicates a critical role for calcium in the regulation of C.
albicans morphogenesis (40). Calcineurin is a major player in eukaryotic calcium-
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dependent signal transduction pathways. In C. albicans, the calcineurin pathway has
been shown to be involved in tolerance to antifungal agents, cation homeostasis, and
virulence. However, studies of the role of the calcineurin/calmodulin pathway in C.
albicans hyphal growth and bioﬁlm formation have revealed contradictory results (41).
Calcineurin is a calcium-dependent serine/threonine-speciﬁc protein phosphatase, and
studies have identiﬁed at least 15 novel downstream signaling targets in yeast (42).
These downstream targets have been found to play roles in modulating the cell cycle,
membrane structure, and cell wall integrity (42). In this study, PHCl was found to
decrease C. albicans cell surface hydrophobicity. Cell surface hydrophobicity has been
shown to be related to cell wall composition and is also a predictor of bioﬁlm-forming
capability in Candida species (43). Cell adhesion to host surfaces is regarded as a major
virulence factor for C. albicans (44). Therefore, these ﬁndings suggest that cholinergic
signaling inhibits C. albicans virulence by additional mechanisms, possibly regulated by
intracellular calcium via the calcineurin/calmodulin pathway. However, further research
is required to conﬁrm this hypothesis.
C. albicans-triggered diseases represent an intriguing immunological paradigm as
they result from a disrupted balance between tolerance and resistance by the immune
system (45). The host immune response must eliminate the fungus while limiting
collateral damage to tissues and restoring a homeostatic environment. The invasive
growth of C. albicans, however, triggers a strong host inﬂammatory response that can
damage infected organs (46). Acetylcholine has been found to promote rapid clearance
of C. albicans in a G. mellonella infection model, while at the same time protecting
against inﬂammation-induced tissue damage (17). The data in this article show that
PHCl can also modulate host immunity to C. albicans infection with similar outcomes.
Indeed, PHCl not only inhibited ﬁlamentation in vivo but could also promote rapid and
effective clearance of the pathogen while limiting bystander vital tissue damage.
Therefore, PHCl can also modulate the pathogenesis of C. albicans infection via mus-
carinic receptors on G. mellonella immune cell subsets.
Despite similarities between ACh and PHCl in terms of pathogenesis of a C. albicans
infection in G. mellonella, distinct differences in the subtypes of hemocytes involved
were noted. G. mellonella possesses at least six immune cell subsets, granulocytes,
plasmatocytes, oenocytoids, spherulocytes, prohemocytes, and adipohemocytes (47).
Granulocytes, the very ﬁrst cells recruited to counteract pathogen invasion, were
strongly activated in vivo in the presence of ACh, but not PHCl. Similarly, spherulocytes,
whose function is still to be deﬁned, were speciﬁcally recruited into tissues in ACh-
inoculated larvae, but not in PHCl-inoculated larvae. As spherulocyte recruitment is
known to be dependent on granulocyte recruitment, this ﬁnding is perhaps unsurpris-
ing. However, a direct inhibitory effect of PHCl on spherulocyte recruitment cannot be
ruled out. In addition to hemocyte recruitment, PHCl was found to promote less
hemocyte aggregation in vivo than ACh, and the resulting nodules were mainly
characterized by the presence of plasmatocytes, which are usually necessary during the
later phases of nodulation and encapsulation.
In this study, differences between in vitro- and in vivo-stimulated hemocytes, both
in terms of morphology and quantity, were observed. In particular, under all conditions
investigated, the in vitro spherulocyte content was reduced compared with the in vivo
spherulocyte content, as spherulocytes do not originate from division of circulating
hemocytes but are derived from the granulocyte lineage of hematopoietic organs (48).
We hypothesize therefore that the biological functions of ACh and PHCl may also be
modulated by larval tissue or plasma factors that are missing in cultured cells. Indeed,
the fat body of G. mellonella plays a crucial metabolic function, producing antimicrobial
peptides and proteins that are involved in dictating immune responses.
The data in this article suggest that cholinergic receptors can modulate G. mellonella
hematopoiesis and differentiation. Interestingly, in humans, cholinergic receptors have
been shown to regulate hematopoiesis (49). Platelet and megakaryocyte precursors
(50), as well as myeloid and erythroid progenitors in the bone marrow (51), all express
the 7nAChR which is suggested to play a vital role in regulating their differentiation
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and maturation. Therefore, it is interesting to speculate that similar systems operate in
G. mellonella. However, further research using speciﬁc cholinergic receptor agonist and
antagonists is required to begin to delineate the type of cholinergic receptors that
regulate G. mellonella cellular immunity. The fact that ACh, and not PHCl, induced
hemocyte recruitment and aggregation suggests that nicotinic receptors rather than
muscarinic receptors may play a more important role in immune regulation in this
model host.
In conclusion, the present study suggests that different cholinergic receptors may
be involved in the promotion of favorable outcome to C. albicans systemic infection. A
muscarinic-type receptor seems to modulate C. albicans ﬁlamentation and bioﬁlm
formation. In addition, the data suggest that hemocyte subsets of G. mellonella possess
different repertoires of cholinergic receptors that can modulate their differentiation and
function. Therefore, this article provides evidence that targeting cholinergic receptors
by repurposing currently licensed cholinergic drugs may be a direct or adjunctive
therapeutic strategy to prevent or treat potentially fatal fungal infections.
MATERIALS AND METHODS
Candida albicans yeast culture and bioﬁlm formation. C. albicans SC5314 was subcultured and
propagated as described previously (17). C. albicans SC5314 was then standardized to 1 106
cells/ml in Roswell Park Memorial Institute 1640 medium (RPMI 1640) in the presence or absence of
various concentrations of pilocarpine hydrochloride (PHCl) (Tocris, UK) or SIB1508Y maleate (Tocris, UK).
To determine speciﬁcity of action, experiments were also performed with PHCl in the presence or
absence of various concentrations of scolopamine (SCP) (Tocris, UK). Standardized cells were allowed
to form bioﬁlms in ﬂat-bottomed 96-well microtiter plates at 37°C for 24 h. Following incubation,
metabolic activity was assessed using the 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide) (XTT) assay and bioﬁlm biomass determined using the crystal violet assay as described
previously (52). Experimental conditions were run in triplicate. Results are presented as mean values from
at least four independent experiments.
Propidium iodide uptake and ATP release assays. To evaluate whether any indirect antifungal
activity through the disruption of the cell membrane was induced by PHCl, we used a propidium iodide
(PI) uptake and ATP release assay, as previously described (29). Brieﬂy, C. albicans SC5314 was standard-
ized to 5 107 cells/ml in RPMI 1640 and treated with 50 mM PHCl for 60 min. After treatment, the
supernatant was harvested, and the cells were washed with PBS and treated with 2 M PI (in PBS). After
incubation at 37˚C for 15 min, ﬂuorescence was measured at excitation and emission wavelengths of 485
and 620 nm, respectively. The ATP release assay was performed according to the manufacturer’s
instructions on supernatants harvested after 60 min using an ATP bioluminescent assay kit (Sigma-
Aldrich, UK). Experimental conditions were run in triplicate and repeated on three independent occa-
sions.
Bioﬁlm viability and cell morphology. Standardized C. albicans SC5314 (1 106 cells/ml) were
inoculated in RPMI with or without PHCl on Thermanox coverslips (13 mm) within a 24-well tissue culture
plate and then incubated for 24 h at 37°C. For light microscopy, coverslips were washed gently with PBS
and stained with crystal violet (0.05% [vol/vol]). For ﬂuorescence microscopy, the coverslips were washed
gently with PBS and stained according to the manufacturers’ instructions with 5 M calcoﬂuor white
(CFW) (Invitrogen, UK) and 20 M propidium iodide (PI) (Sigma, UK). For scanning electron microscopy
(SEM), the specimens were prepared as previously described (53). Bioﬁlms were visualized under a
ﬂuorescence microscope (Motic BA400 Colorview system) in normal light mode for crystal violet-stained
coverslips or at Ex350/Em400 for calcoﬂuor white-stained coverslips and Ex540/Em525 for propidium
iodide-stained coverslips. For SEM, bioﬁlms were visualized by using a JEOL JSM-6400 scanning electron
microscope. Representative images from 10 ﬁelds were taken. Experiments were repeated in duplicate
on at least three independent occasions, and representative images are shown.
Microbial adhesion to hydrocarbon assay. The ability of yeast cells to adhere to a hydrocarbon
source (Octane; Sigma, Italy) was used to measure cell surface hydrophobicity (CSH), as previously
described (43). Brieﬂy, C. albicans SC5314 was cultured in YPD (planktonic cells), RPMI 1640 alone
(bioﬁlm), or RPMI 1640 with 6.25, 12.5, and 25 mM PHCl for 24 h. The cells were then standardized to 108
cells/ml and mixed with octane for 2 min. The aqueous and organic phases were allowed to separate for
10 min at 30°C, and the optical density of the aqueous phase was determined at OD600. The CSH index
was calculated as follows: percent CSH  [1  (B  A)]  100 (where A is the initial absorbance of the
aqueous phase, and B is the absorbance of the aqueous phase after partitioning). Samples were run in
duplicate. Results are presented as mean values from ﬁve independent experiments.
Galleria mellonella killing assay. Pathogenicity of C. albicans SC5314 with or without PHCl was
assessed using the G. mellonella killing assay as described previously (17). Sixteen randomly selected
sixth-instar G. mellonella larvae (Allevamento Cirà, Como, Italy) with a body weight of between 200 to
300 mg were employed for each experimental group. Overnight YPD cultures of C. albicans SC5314 were
standardized in PBS to the desired cell density. Larvae were inoculated into the hemocoel with 5 105
cells/larva with or without PHCl at different concentrations using a 10-l Hamilton syringe with a
26-gauge needle. In addition, larvae inoculated with PBS and PHCl alone were included for control
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purposes. A group injected simultaneously with PHCl with or without SCP was further added to verify the
speciﬁcity of PHCl action. The inoculated larvae were incubated at 37°C, and the number of dead larvae
was scored daily. All experiments were repeated on three independent occasions.
Hemocyte characteristics. For the in vitro experiments, the hemolymph of ﬁve G. mellonella larvae
was collected into ice-cold Grace’s medium (Sigma-Aldrich, Italy) by lateral bleeding corresponding to
the last right proleg. Hemocytes were counted and plated onto coverslips in a 24-well plate. The plates
were incubated for 2 h to allow hemocytes to adhere prior to stimulation with C. albicans SC5314 (102
yeast cells/well) for 24 h in the presence and absence of PHCl or ACh. After treatment, hemocytes were
ﬁxed in 4% paraformaldehyde and stained with hematoxylin and eosin. Hemocytes incubated in media
alone acted as a control.
For the in vivo experiments, G. mellonella larvae were inoculated using the same conditions described
for the killing assay. Twenty-four hours after treatment, hemocytes were isolated from the larvae as
described above. Hemocytes from three larvae for each experimental condition were then pooled and
plated onto coverslips in a 24-well plate. The coverslips were centrifuged for 3 min at 300  g at room
temperature and ﬁxed in 4% paraformaldehyde and stained with hematoxylin and eosin.
In both in vitro and in vivo experiments, hemocyte proliferation (cellularity), subtype differentiation
and nodule formation were assessed in comparison to hemocytes incubated in media only (in vitro) or
hemocytes from sham-inoculated larvae (in vivo) A single trained and experienced pathologist (M.
Falleni) carried out all characterization and quantiﬁcation.
Larval histology. After hemolymph extraction, the same larvae were processed for histology as
previously described (54). Brieﬂy, the larvae were inoculated with buffered formalin and processed by
means of transverse cut serial sections. Tissue sections were embedded in parafﬁn and routinely
processed for conventional histopathology. Serial 4-m tissue sections were stained with hematoxylin
and eosin (HE) or periodic acid-Schiff stain (PAS). Image acquisition was performed by the
NanoZoomer-XR C12000 series (Hamamatsu Photonics). To investigate C. albicans ﬁlamentation and the
effect on cellular immunity in vivo, two time points were used, 24 and 48 h. Data were conﬁrmed in three
independent experiments, and representative images are shown.
Statistical analysis. Graph production, data distribution, and statistical analysis were performed
using GraphPad Prism (version 4; La Jolla, CA). Crystal violet and XTT data were found to be abnormally
distributed; therefore, all concentrations were compared to the control using a Kruskal-Wallis nonpara-
metric test with a Dunns post-test. The ATP assay data were found to be normally distributed; therefore,
a Tukey’s multiple-comparison test was used for statistical analysis. The G. mellonella survival curves were
analyzed using a log rank test. Statistical signiﬁcance was achieved if P 0.05.
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